Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hydrolysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104262441A reveals one-step halometasone synthesis. Higher yield, reduced toxicity, cost reduction in pharmaceutical intermediates manufacturing.
Discover a novel preparation method for Ketorolac Tromethamine eliminating thermal decarboxylation. Achieve >99.9% purity with reduced costs and enhanced supply chain reliability.
Novel 2-step synthesis of biphenyl alcohol acid via partial hydrolysis. Reduces steps, eliminates acetic anhydride, lowers cost for API manufacturing.
Patent CN101945861A reveals a novel alkaline hydrolysis and one-pot oxidation route for benzamide insecticides, offering significant supply chain and cost advantages.
Advanced membrane filtration and enzymatic hydrolysis process for high-purity 7-ACA production, offering significant cost reduction and supply chain stability.
Patent CN102795993B reveals a cost-effective nitration-hydrolysis route for high-purity 2-bromo-6-fluorobenzoic acid, offering significant supply chain advantages for pharmaceutical manufacturing.
Patent CN1228341C details a novel camptothecin synthesis from 9-methoxycamptothecin, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN1968938B reveals a breakthrough hexahydrotriazine route for thiazole synthesis, offering superior yield and reduced byproducts for pharmaceutical manufacturing.
Patent CN111116328A reveals a cost-effective route for metoprolol intermediates. Discover supply chain advantages and high-purity manufacturing insights for API production.
Patent CN102702138B details a novel adsorption and alkali treatment method for Repaglinide, achieving >99.6% purity and offering significant cost reduction in API manufacturing.
Patent CN103243141B enables one-pot aqueous synthesis of gamma-glutamyl peptides. Reduces solvent waste and improves yield for pharmaceutical intermediate manufacturing supply chains.
Patent CN101906447B reveals a biocatalytic route for 3,6-dichloropyrimidine-2-carboxylic acid. This method offers significant cost reduction in agrochemical manufacturing and enhanced supply chain reliability.
Patent CN114213306A details a high-purity synthesis route for Brivaracetam acid impurity, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN103665038B enables room temperature synthesis of high-purity chiral phosphine oxides, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN102827912B reveals a novel two-enzyme one-step method for D-7-ACA production, offering significant cost reduction in antibiotic manufacturing and enhanced supply chain reliability.
Novel oxaziridine route for carbidopa offers high yield and purity. Cost-effective pharma intermediate manufacturing solution for global supply chains.
Optimized synthesis of (4-chloro-2-phenoxyphenyl)acetic acid via CN102976929A. Delivers cost reduction in API intermediate manufacturing and enhanced supply reliability.
Patent CN116287086B reveals enzymatic water-phase synthesis for tazobactam. Offers cost reduction in pharmaceutical intermediates manufacturing and high-purity output.
Patent CN110272839A enables high-purity chiral acid synthesis. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing for global partners.
Patent CN102757924A details a novel Rhodococcus strain for high-purity (S)-(+)-DMCPA production, offering superior enantioselectivity and scalable manufacturing for cilastatin synthesis.